Biora Therapeutics (NASDAQ:BIOR – Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter.
Biora Therapeutics (NASDAQ:BIOR – Get Free Report) last posted its quarterly earnings results on Tuesday, March 26th. The company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.03). On average, analysts expect Biora Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Biora Therapeutics Stock Down 1.5 %
Shares of NASDAQ BIOR opened at $0.74 on Wednesday. The stock has a market capitalization of $26.57 million, a PE ratio of -0.09 and a beta of 1.22. The firm has a fifty day moving average of $0.91 and a 200-day moving average of $1.14. Biora Therapeutics has a 52-week low of $0.59 and a 52-week high of $6.70.
About Biora Therapeutics
Biora Therapeutics, Inc, a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases.
Featured Articles
- Five stocks we like better than Biora Therapeutics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How to Read an Earnings Report | Step by Step Guide with Tips
- Financial Services Stocks Investing
- Datadog: In the Doghouse or Pullback to the Buyzone?
- Election Stocks: How Elections Affect the Stock Market
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.